Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement
- Author:
Miseon KIM
1
;
Tae Wook KONG
;
Sunghoon KIM
;
Seung Cheol KIM
;
Yong Beom KIM
;
Jae Weon KIM
;
Jeong Yeol PARK
;
Dong Hoon SUH
;
Seung Hyuk SHIM
;
Keun Ho LEE
;
Sung Jong LEE
;
Jae Kwan LEE
;
Myong Cheol LIM
Author Information
- Publication Type:Original Article
- Keywords: Uterine Cervical Neoplasms; Hysterectomy; Minimally Invasive Surgical Procedures; Laparoscopy; Laparotomy
- MeSH: Endoscopy; Female; Gynecology; Humans; Hysterectomy; Laparoscopy; Laparotomy; Minimally Invasive Surgical Procedures; Obstetrics; Prospective Studies; Survival Rate; Uterine Cervical Neoplasms
- From:Journal of Gynecologic Oncology 2019;30(5):e104-
- CountryRepublic of Korea
- Language:English
- Abstract: On the basis of emerging data and the current understanding of minimally invasive surgery (MIS) for radical hysterectomy (RH) in women with cervical cancer, the Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery support the following recommendations: • According to the recently published phase III Laparoscopic Approach to Cervical Cancer (LACC) trial—a prospective randomized clinical trial—disease-free survival and overall survival rates of MIS RH are significantly lower than those of open RH. • Gynecologic oncologists should be aware of the emerging data on MIS RH for early-stage cervical cancer. • The results of the LACC trial, together with institutional data, should be discussed with patients before choosing MIS RH. • MIS RH should be performed for optimal candidates according to the current practice guidelines by gynecologic oncologists who are skilled at performing MIS.
